USD 1.97 billion
Cancer Gene Therapy Market Size, Share, Growth Analysis, By Therapy(Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By Indication(Breast Cancer, Ovarian Cancer, Liver Cancer, Pancreatic Cancer), By End User(Hospitals, Diagnostic centers, Research Institutes, and Others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35G2180 |
Region:
Global |
Published Date: July, 2024
Pages:
157
|Tables:
95
|Figures:
76
Cancer Gene Therapy Market Insights
Cancer Gene Therapy Market size was valued at USD 2.86 Billion in 2023 and is poised to grow from USD 3.44 Billion in 2024 to USD 15.21 Billion by 2032, growing at a CAGR of 20.42% during the forecast period (2025-2032).
The global increase in incidence of cancer is setting the tone for cancer gene therapy market growth. Rising demand for novel cancer treatments, advancements in genetic engineering, and high investments in development of new cancer therapies are slated to be key factors driving cancer gene therapy demand. Advancements in gene technologies and growing research on its application in oncology are pushing companies to develop novel cancer gene therapies. Growing demand for personalized cancer treatments to improve mortality rates and supportive government funding to help cancer patients are also expected to create new opportunities for cancer gene therapy providers in the future. On the other hand, high costs of treatment, risk of adverse reactions, and manufacturing challenges are estimated to constrain cancer gene therapy market development potential in the long run.
US Cancer Gene Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
viral gene therapy
Fastest Growth
viral gene therapy
Growth Rate
20.42% CAGR
Global Cancer Gene Therapy Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Cancer Gene Therapy Market Segmental Analysis
The global cancer gene therapy market is segmented into therapy, indication, end user and region. Based on therapy, it is divided into gene induced immunotherapy, oncolytic virotherapy, and gene transfer. Based on indication, the market is segmented into breast cancer, ovarian cancer, liver cancer, Pancreatic Cancer Treatment, lung cancer, prostate cancer, and others. Based on end user the market is further segmented into hospitals, diagnostic centers, research institutes, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Indication
The demand for cancer gene therapy for treatment of breast cancer is projected to account for a dominant share of the global market. Rising awareness regarding breast cancer among women and growing emphasis on early diagnosis of the same are helping this segment secure a top spot. Growing investments in the development of novel treatments for breast cancer are also expected to help market growth via this segment.
Meanwhile, the demand for cancer gene therapy for lung cancer is slated to increase at a robust pace across the forecast period and beyond. Surging prevalence of lung cancer around the world owing to increasing tobacco consumption and air pollution is boosting cancer gene therapy demand. Companies should focus on capitalizing on this indication as interest in treating lung cancer around the world is increasing rapidly.
Analysis by Therapy
Gene-induced therapy offers the patient the best of both worlds by bringing together the advantages of gene therapy and immunotherapy. This is why this therapy holds a dominant stance in the global market. Advancements in genome technologies and research on genetic factors impacting cancer are also expected to help this segment promote market growth in the future.
On the other hand, the demand for oncolytic virotherapy is estimated to increase at a rapid CAGR over the coming years. High efficacy and better patient outcomes of oncolytic virotherapy are making them popular among healthcare professionals and patients. Growing investments in the development of novel oncolytic virotherapy are also expected to help promote market development at a rapid CAGR through 2031.
Global Cancer Gene Therapy Market By Therapy Type
To get detailed analysis on other segments, Request For Free Sample Report
Cancer Gene Therapy Market Regional Insights
Lucrative environment offered by public and private institutions in the North American region to advance oncology research is what allows this region to hold a high market share. The United States is projected to remain the top market in this region owing to quick adoption of novel healthcare treatments and presence of a developed healthcare infrastructure. Canada is also an opportune market for cancer gene therapy companies in this region.
Meanwhile, the demand for cancer gene therapy in the European region is slated to rise at a notable pace over the coming years. Apart from the growing incidence of different types of cancers, increasing collaborations and partnerships among healthcare and medical organizations to boost oncology research are helping this region’s growth potential. Germany, France, and the United Kingdom are slated to be the most opportune markets for cancer gene therapy providers looking to make a mark in the European region.
Global Cancer Gene Therapy Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cancer Gene Therapy Market Dynamics
Cancer Gene Therapy Market Drivers
Advancements in Gene Technologies
- Genetic engineering and genome mapping technologies have a come a long way owing to high investments in gene research initiatives. These advancements from the gene world are now being integrated with oncology research to create novel cancer gene therapies thereby driving market growth as well.
High Investments in Oncology Research
- With cancer becoming a global pandemic, the need for novel cancer treatments is higher than ever before. This is why governments and healthcare companies are continually investing heavily in oncology research to develop new treatments and cures.
Restraints
High Costs of Treatment
- Getting cancer gene therapy is not possible for every cancer patient as they are quite expensive owing to their use of advanced equipment and extensive development costs. These high costs of treatment slow down cancer gene therapy adoption.
Adverse Reaction Risks
- While gene therapies are gaining popularity, the risk of adverse reactions and rejections are also being popularized. These risks are inevitable now, and this is slowing down cancer gene therapy demand to a certain extent.
Request Free Customization of this report to help us to meet your business objectives.
Cancer Gene Therapy Market Competitive Landscape
Cancer gene therapy providers should be targeting regions and countries with high incidence of cancer to maximize their business scope. Collaborating and partnering with healthcare providers could also help market players increase their revenue generation potential. Investing in research and development is highly essential for cancer gene therapy types of cancer gene therapy companies in the long run.
Cancer Gene Therapy Market Top Player’s Company Profiles
- Novartis AG (Switzerland)
- Gilead Sciences, Inc. (United States)
- Bristol-Myers Squibb (United States)
- Pfizer Inc. (United States)
- Merck & Co., Inc. (United States)
- Celgene Corporation (United States)
- Amgen Inc. (United States)
- Johnson & Johnson (United States)
- AstraZeneca (United Kingdom)
- GlaxoSmithKline plc (United Kingdom)
- bluebird bio, Inc. (United States)
- CRISPR Therapeutics AG (Switzerland)
- Editas Medicine, Inc. (United States)
- Intellia Therapeutics, Inc. (United States)
- uniQure N.V. (Netherlands)
- Sarepta Therapeutics, Inc. (United States)
- GenSight Biologics (France)
- Oncorus, Inc. (United States)
- MeiraGTx Holdings plc (United Kingdom)
- Tocagen Inc. (United States)
Cancer Gene Therapy Market Recent Developments
- In January 2023, GenoCure Pharmaceuticals, a leading biotechnology company, unveiled a novel gene therapy approach that effectively targets and eliminates solid tumors, offering renewed hope for cancer patients.
- In March 2023, ThermaGene Therapeutics, a pioneer in gene therapy, launched a cutting-edge gene delivery system that enhances the efficiency and safety of cancer gene therapies.
- In June 2023, OmniGene Therapeutics, a clinical-stage biopharmaceutical company, released positive data from a Phase II clinical trial of their cancer gene therapy.
Cancer Gene Therapy Key Market Trends
- Demand for Combination Therapies: Growing number of cancer patients are opting for combination therapies to improve their chances of survival and get better treatment. Cancer gene therapy providers can focus on the development of new combination therapies to maximize their business scope in the long run.
Cancer Gene Therapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, growing prevalence of cancer and high investments in oncology research are projected to bolster cancer gene therapy demand over the coming years. On the contrary, high costs of treatment, risk of adverse reactions, and manufacturing challenges are slated to impede cancer gene therapy market growth going forward. Europe is slated to emerge as the fastest-expanding regional market in the world owing to rising awareness regarding cancer indications. Gene-induced immunotherapy is slated to bring in the most revenue for cancer gene therapy market players. Developing combination therapies will pay off big time for new as well as leading cancer gene therapy providers through 2031 and beyond.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 2.86 Billion |
| Market size value in 2032 | USD 15.21 Billion |
| Growth Rate | 20.42% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Cancer Gene Therapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Cancer Gene Therapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Cancer Gene Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cancer Gene Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cancer Gene Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cancer Gene Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
